Anitoa Unveil Maverick, an ultra-portable qPCR system

"We are excited to bring to the market a portable quantitative-polymerase-chain-reaction (qPCR) device with performance that rivals the most expensive lab-based systems, at a fraction of the cost," said Dr. Zhimin Ding, CEO of Anitoa Systems. "We strive to make our molecular testing systems rugged, accessible, and with battery operation and power-loss protection capability to facilitate their effective use in low resource settings." The Maverick technology was shown to detect several types of pathogen DNA and RNA strands, such as Hepatitis B and C, HIV, E. coli and many of their drug-resistant variants. The system can reliably detect 4 copies pathogen molecule DNA per sample with over 9 orders of magnitude in dynamic range. @ https://www.prnewswire.com/news-releases/anitoa-unveils-ultra-portable-qpcr-system-at-molecular-med-tri-con-2018-300597348.html" rel="nofollow noopener noreferrer" target="_blank">https://www.prnewswire.com/news-releases/anitoa-unveils-ultra-portable-qpcr-system-at-molecular-med-tri-con-2018-300597348.html
Anitoa Unveils Ultra-portable qPCR System at Molecular Med Tri-con 2018

MENLO PARK, Calif., Feb. 13, 2018 /PRNewswire/ — Anitoa Systems, LLC, a Menlo Park, California-based medical device…

No comments

Leave a Reply